195 related articles for article (PubMed ID: 34327862)
1. Impacts of anti-inflammatory phosphodiesterase inhibitors on a murine model of chronic pulmonary inflammation.
Zheng XF; Chen DD; Zhu XL; Le Grange JM; Zhou LQ; Zhang JN
Pharmacol Res Perspect; 2021 Aug; 9(4):e00840. PubMed ID: 34327862
[TBL] [Abstract][Full Text] [Related]
2. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
3. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease.
To Y; Ito K; Kizawa Y; Failla M; Ito M; Kusama T; Elliott WM; Hogg JC; Adcock IM; Barnes PJ
Am J Respir Crit Care Med; 2010 Oct; 182(7):897-904. PubMed ID: 20224070
[TBL] [Abstract][Full Text] [Related]
4. Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke.
Martorana PA; Beume R; Lucattelli M; Wollin L; Lungarella G
Am J Respir Crit Care Med; 2005 Oct; 172(7):848-53. PubMed ID: 15961691
[TBL] [Abstract][Full Text] [Related]
5. [Roflumilast: clinical review of a new option for the treatment of inflammation in COPD].
Martínez FJ
Arch Bronconeumol; 2010 Nov; 46 Suppl 9():8-11. PubMed ID: 21320811
[No Abstract] [Full Text] [Related]
6. Low-dose theophylline restores corticosteroid responsiveness in rats with smoke-induced airway inflammation.
Sun X; Li Q; Gong Y; Ren L; Wan H; Deng W
Can J Physiol Pharmacol; 2012 Jul; 90(7):895-902. PubMed ID: 22708526
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of roflumilast with dexamethasone in a neutrophilic asthma mouse model.
Park CK; An TJ; Kim JH; Rhee CK; Yoon HK
Clin Exp Pharmacol Physiol; 2022 Jun; 49(6):624-632. PubMed ID: 35181901
[TBL] [Abstract][Full Text] [Related]
8. Roflumilast increases Clara cell secretory protein in cigarette smoke-exposed mice.
Ge XN; Chu HW; Minor MN; Case SR; Bosch DG; Martin RJ
COPD; 2009 Jun; 6(3):185-91. PubMed ID: 19811374
[TBL] [Abstract][Full Text] [Related]
9. Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD.
Giembycz MA; Field SK
Drug Des Devel Ther; 2010 Jul; 4():147-58. PubMed ID: 20689641
[TBL] [Abstract][Full Text] [Related]
10. Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma.
Field SK
Expert Opin Investig Drugs; 2008 May; 17(5):811-8. PubMed ID: 18447606
[TBL] [Abstract][Full Text] [Related]
11. Alternatives to indicating roflumilast and the chronic obstructive pulmonary disease classification.
Blasco LM
Arch Bronconeumol; 2012 Sep; 48(9):343. PubMed ID: 22503591
[No Abstract] [Full Text] [Related]
12. Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitor.
Gross NJ; Giembycz MA; Rennard SI
COPD; 2010 Apr; 7(2):141-53. PubMed ID: 20397815
[TBL] [Abstract][Full Text] [Related]
13. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.
Calverley PM; Rabe KF; Goehring UM; Kristiansen S; Fabbri LM; Martinez FJ;
Lancet; 2009 Aug; 374(9691):685-94. PubMed ID: 19716960
[TBL] [Abstract][Full Text] [Related]
14. Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury.
Cortijo J; Iranzo A; Milara X; Mata M; Cerdá-Nicolás M; Ruiz-Saurí A; Tenor H; Hatzelmann A; Morcillo EJ
Br J Pharmacol; 2009 Feb; 156(3):534-44. PubMed ID: 19154443
[TBL] [Abstract][Full Text] [Related]
15. Callicarpa japonica Thunb. attenuates cigarette smoke-induced neutrophil inflammation and mucus secretion.
Lee JW; Shin NR; Park JW; Park SY; Kwon OK; Lee HS; Hee Kim J; Lee HJ; Lee J; Zhang ZY; Oh SR; Ahn KS
J Ethnopharmacol; 2015 Dec; 175():1-8. PubMed ID: 26342519
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease.
Doggrell SA
Expert Opin Pharmacother; 2006 Mar; 7(4):485-8. PubMed ID: 16503820
[No Abstract] [Full Text] [Related]
17. Glucocorticoid Receptor α Mediates Roflumilast's Ability to Restore Dexamethasone Sensitivity in COPD.
Reddy AT; Lakshmi SP; Banno A; Reddy RC
Int J Chron Obstruct Pulmon Dis; 2020; 15():125-134. PubMed ID: 32021151
[TBL] [Abstract][Full Text] [Related]
18. Baicalin is anti-inflammatory in cigarette smoke-induced inflammatory models in vivo and in vitro: A possible role for HDAC2 activity.
Li L; Bao H; Wu J; Duan X; Liu B; Sun J; Gong W; Lv Y; Zhang H; Luo Q; Wu X; Dong J
Int Immunopharmacol; 2012 May; 13(1):15-22. PubMed ID: 22421405
[TBL] [Abstract][Full Text] [Related]
19. Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.
Hardaker EL; Freeman MS; Dale N; Bahra P; Raza F; Banner KH; Poll C
Br J Pharmacol; 2010 Aug; 160(8):1985-96. PubMed ID: 20649596
[TBL] [Abstract][Full Text] [Related]
20. Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice.
Raju SV; Rasmussen L; Sloane PA; Tang LP; Libby EF; Rowe SM
Respir Res; 2017 Sep; 18(1):173. PubMed ID: 28923049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
